Washington University School of MedicineAdvanced Technology Consortium

Members Credentialing Protocols Publications Resources Home

The Advanced Technology QA Consortium

The Advanced Technology Consortium for Clinical Trials Quality Assurance (ATC) is supported by a National Cancer Institute U24 grant to Washington University. It has grown out of the efforts of Washington University and the Radiation Therapy Oncology Group, beginning in 1994, to create a robust Quality Assurance process to collect and review the image-based planning and verification data for patients enrolled on the 3D Oncology Group (3DOG) prostate dose-escalation protocol (RTOG 9406). The ATC now functions as a “virtual entity” made up of the following clinical trials QA Centers:
  • Image-Guided Therapy QA Center (ITC - Washington Univ. in St. Louis and UC Davis),
  • Radiation Therapy Oncology Group (RTOG) Headquarters Dosimetry Group,
  • Radiological Physics Center (RPC, M.D. Anderson Cancer Center), and
  • Quality Assurance Review Center (QARC).
The ATC capitalizes on the existing infrastructure and strengths of national QA programs. Its overall mission is to facilitate and support NCI sponsored advanced technology clinical trials, particularly those requiring digital data submission. This effort includes radiation therapy QA, image and radiation therapy digital data management, and clinical research and developmental efforts. Efforts are made to utilize each group's strengths and avoid duplication of existing programs. We strongly believe that advanced medical informatics can create an environment in which clinical investigators can receive, share, and analyze volumetric, multimodality treatment planning and verification digital data. Our ultimate goal is to improve the standards of care in the management of cancer by improving the quality of clinical trials medicine.

Back to FAQs